1 min read
Adagio Medical Reports $17.8 Million Q3 Net Income and $5.13 Diluted EPS Loss
Basic EPS was $2.40, and cash and cash equivalents totaled $3.1 million on Sept. 30, 2026.

Adagio Medical Holdings, Inc. (ADGM) reported $17.8 million in net income for the third quarter of 2026, alongside diluted net loss per share of $5.13. Basic earnings per share was $2.40.
The $5.13 diluted figure primarily reflected the exclusion of a noncash fair-value gain. The company had $3.1 million in cash and cash equivalents as of Sept. 30, 2026.